Shelston IP’s immunology expertise is headed by Principal Dr Grant Shoebridge, who obtained his PhD from the Immunobiology Unit, University of Technology, Sydney.
Australia’s strong international reputation for immunology research is mirrored by the extensive expertise of the attorneys in Shelston IP’s immunology team. This expertise includes doctoral and post-doctoral research experience in all aspects of immunology, including molecular immunology, cellular immunology, antibody therapeutics, immunotherapy and vaccine development.
Our collective immunology expertise is complemented by the knowledge our attorneys possess as a result of working in a diverse range of research laboratories investigating: infectious diseases, such as HIV and tuberculosis; cancer, inflammatory diseases and neurological disease states, including Alzheimer’s disease and multiple sclerosis.
The wide-ranging immunology expertise of our attorneys makes them perfectly placed to deal with all aspects of immunology patents and applications, including: drafting; prosecution; conducting opposition proceedings; and providing validity and infringement advice.